Case number 2015-2066
Millennium Pharmaceuticals v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MILLENNIUM PHARMACEUTICALS v. SANDOZ INC. [OPINION] [precedential] (0) |
| Oct 27, 2017 | 153 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [471000] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [SJ] [Entered: 10/27/2017 09:40 AM] (2) |
| Oct 20, 2017 | 151 | MOTION of Appellee Apotex Corp. to withdraw counsel Luke T. Shannon. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/20/2017 by email. [469512] [Thomas Ehrich] [Entered: 10/20/2017 02:41 PM] (5) |
| Oct 20, 2017 | 152 | **TEXT ONLY** ORDER granting motion to withdraw attorney [151] Luke T. Shannon filed by Appellees Apotex Corp. and Apotex Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [469563] [SJ] [Entered: 10/20/2017 04:24 PM] (0) |
| Oct 19, 2017 | 150 | ORDER filed denying [146] petition for panel rehearing filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited; denying [146] petition for en banc rehearing filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [469158] [SJ] [Entered: 10/19/2017 01:53 PM] (2) |
| Oct 12, 2017 | 148 | MOTION of Appellant Millennium Pharmaceuticals, Inc. to withdraw counsel Anna E. Lumelsky. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/12/2017 by email. [467332] [Anna Lumelsky] [Entered: 10/12/2017 12:21 PM] (6) |
| Oct 12, 2017 | 149 | **TEXT ONLY** ORDER granting motion to withdraw attorney [148] Anna E. Lumelsky filed by Appellant Millennium Pharmaceuticals, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [467345] [SJ] [Entered: 10/12/2017 12:57 PM] (0) |
| Sep 18, 2017 | 147 | 18 paper copies of the petition for panel rehearing [146], petition for en banc rehearing [146] received from Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. [461731] [SJ] [Entered: 09/18/2017 01:20 PM] (0) |
| Sep 15, 2017 | 143 | Corrected Entry of appearance for George C. Lombardi as of counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461408] [George Lombardi] [Entered: 09/15/2017 03:06 PM] (2) |
| Sep 15, 2017 | 144 | Corrected Entry of appearance for Steffen N. Johnson as principal counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461416] [Steffen Johnson] [Entered: 09/15/2017 03:13 PM] (2) |
| Sep 15, 2017 | 145 | Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellee Sandoz Inc.. Service: 09/15/2017 by email. [461428] [Eimeric Reig-Plessis] [Entered: 09/15/2017 03:29 PM] (2) |
| Sep 15, 2017 | 146 | Petition for panel rehearing, for en banc rehearing filed by Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC. Service: 09/15/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 09/19/2017 [461545] [Steffen Johnson] [Entered: 09/15/2017 05:14 PM] (61) |
| Aug 15, 2017 | 142 | ORDER filed granting motion to extend time to file petition for rehearing [139] filed by Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hospira, Inc., Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd., Accord Healthcare, Inc., Glenmark Generics Ltd., Sun Pharma Global FZE, Actavis LLC, Sandoz Inc., Wockhardt USA LLC, Wockhardt Bio AG, Mylan Laboratories Limited, Agila Specialties Inc. and Sun Pharmaceutical Industries Limited Petition for Rehearing due on or before 09/15/2017. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [454004] [SJ] [Entered: 08/15/2017 10:52 AM] (2) |
| Aug 9, 2017 | 137 | Entry of appearance for Steffen N. Johnson as of counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452641] [Steffen Johnson] [Entered: 08/09/2017 12:41 PM] (2) |
| Aug 9, 2017 | 138 | Entry of appearance for Andrew C. Nichols as principal counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452643] [Andrew Nichols] [Entered: 08/09/2017 12:44 PM] (2) |
| Aug 9, 2017 | 139 | MOTION of Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC to extend the time to file a Petiton or Panel Rehearing until 09/15/2017. [Consent: unopposed]. Service: 08/09/2017 by email. [452647]--[Edited 08/09/2017 by JP to remove incorrect filer party - Teva Pharmaceuticals USA, Inc.] [Andrew Nichols] [Entered: 08/09/2017 12:58 PM] (21) |
| Aug 9, 2017 | 140 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [138] filed by Appellee Sandoz Inc. in 15-2066 is indicating more than one principal attorney for the party(s) and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency [either Mr. Lombardi or Mr. Nichols must amend their appearance to reflect 'of counsel', or withdraw]. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [452660] [SJ] [Entered: 08/09/2017 01:24 PM] (0) |
| Aug 9, 2017 | 141 | Corrected Entry of appearance for Andrew C. Nichols as of counsel for Appellee Sandoz Inc.. Service: 08/09/2017 by email. [452683] [Andrew Nichols] [Entered: 08/09/2017 01:54 PM] (2) |
| Jul 17, 2017 | 136 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed-in-part and Remanded-in-part in 15-2066, 16-1008, 16-1009, 16-1010, 16-1110, 16-1283, 16-1762; Vacated-in-part and Remanded-in-part in 16-1109. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [446874] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [JAB] [Entered: 07/17/2017 10:14 AM] (25) |
| Feb 6, 2017 | 135 | Submitted after ORAL ARGUMENT by William F. Lee for Millennium Pharmaceuticals, Inc. and Thomas J. Meloro for Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. Panel: Judge: Newman , Judge: Mayer , Judge: O'Malley. [404790] [JAB] [Entered: 02/06/2017 10:44 AM] (0) |
| Jan 17, 2017 | 133 | Response to oral argument order from the Appellant Millennium Pharmaceuticals, Inc.. designating William F. Lee as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399278] [William Lee] [Entered: 01/17/2017 08:55 AM] (0) |
| Jan 17, 2017 | 134 | Response to oral argument order from the Appellees Accord Healthcare, Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. designating Thomas J. Meloro as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399691] [Thomas Meloro] [Entered: 01/17/2017 04:51 PM] (0) |
| Dec 15, 2016 | 132 | NOTICE OF CALENDARING. Panel: 1702B. Case scheduled Feb 06, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 01/17/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [391314] THIS NOTICE APPLIES TO CASE(S): [15-2066, 16-1179, 16-1591, 16-1788] [JAB] [Entered: 12/15/2016 12:05 PM] (0) |
| Nov 9, 2016 | 131 | Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (December 5, 2016 , January 9-13, February 13, and March 13, 2017). Service: 11/09/2016 by email. [381667] [William Lee] [Entered: 11/09/2016 02:13 PM] (1) |
| Nov 2, 2016 | 130 | Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (December 5-9, 2016; January 9-13, 2017). Service: 11/02/2016 by email. [379816] [William Rakoczy] [Entered: 11/02/2016 03:43 PM] (2) |
| Oct 14, 2016 | 129 | Amended Certificate of Interest for the Appellee Actavis LLC. Service: 10/14/2016 by email. [374540] [Gary Hood] [Entered: 10/14/2016 05:12 PM] (3) |
| Sep 28, 2016 | 128 | Notice from Appellee Hospira, Inc. regarding conflicts with oral argument (December 5-9, 2016 and March 10, 2017). Service: 09/28/2016 by email. [369929] [Thomas Meloro] [Entered: 09/28/2016 02:41 PM] (2) |
| Sep 27, 2016 | 127 | Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (December 5, 2016 and January 9-13, 2017). Service: 09/27/2016 by email. [369548] [William Lee] [Entered: 09/27/2016 12:36 PM] (1) |
| Jul 26, 2016 | 126 | Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (August 1-5, November 4 and 7, and December 5, 2016). Service: 07/26/2016 by email. [353687] [William Lee] [Entered: 07/26/2016 01:19 PM] (1) |
| Jul 18, 2016 | 118 | Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351553] [William Rakoczy] [Entered: 07/18/2016 12:40 PM] (2) |
| Jul 18, 2016 | 119 | Notice from Appellant Millennium Pharmaceuticals, Inc. regarding conflicts with oral argument (August 1-5, November 7, and December 5, 2016). Service: 07/18/2016 by email. [351632] [William Lee] [Entered: 07/18/2016 02:37 PM] (1) |
| Jul 18, 2016 | 120 | Notice from Appellee Accord Healthcare Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351636] [Paul Braier] [Entered: 07/18/2016 02:40 PM] (0) |
| Jul 18, 2016 | 121 | Notice from Appellee Hospira, Inc. regarding conflicts with oral argument (08/05/2016). Service: 07/18/2016 by email. [351658] [Thomas Meloro] [Entered: 07/18/2016 03:05 PM] (2) |
| Jul 18, 2016 | 122 | Notice from Appellee Actavis LLC regarding conflicts with oral argument (August 1-5, September 6-9 or November 7, 2016). Service: 07/18/2016 by email. [351669] [Gary Hood] [Entered: 07/18/2016 03:16 PM] (2) |
| Jul 18, 2016 | 123 | NOTICE OF DEFICIENCY: The party letter Document No. [120] filed by Appellee Accord Healthcare Inc. in 15-2066 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. Please re-file your notice under the correct event "NOTICE REGARDING CONFLICT WITH ARGUMENT DATES." You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [351684] [CAB] [Entered: 07/18/2016 03:27 PM] (0) |
| Jul 18, 2016 | 124 | Notice from Appellee Accord Healthcare Inc. regarding conflicts with oral argument (October 3-7, 2016; December 5-9, 2016). Service: 07/18/2016 by email. [351690] [Paul Braier] [Entered: 07/18/2016 03:34 PM] (2) |
| Jul 18, 2016 | 125 | Notice from Appellees Agila Specialties Inc. and Mylan Laboratories Limited regarding conflicts with oral argument (September 9, 2016). Service: 07/18/2016 by email. [351765] [Elham Steiner] [Entered: 07/18/2016 06:00 PM] (2) |
| Jul 11, 2016 | 116 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/18/2016. [349767] [CAB] [Entered: 07/11/2016 01:10 PM] (0) |
| Jul 11, 2016 | 117 | 6 paper copies of the Joint Appendix (Vol. I-III) [115] received from Appellant Millennium Pharmaceuticals, Inc. [350543] [KW] [Entered: 07/13/2016 02:50 PM] (0) |
| Jul 5, 2016 | 113 | TENDERED from Appellant Millennium Pharmaceuticals, Inc.. Title: JOINT APPENDIX. Service: 07/05/2016 by email. [348533] [William Lee] [Entered: 07/05/2016 05:03 PM] (1704) |
| Jul 5, 2016 | 114 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Millennium Pharmaceuticals, Inc. and Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Wockhardt Bio AG and Wockhardt USA LLC. Service: 07/05/2016 by email. [348535] [William Lee] [Entered: 07/05/2016 05:06 PM] (6) |
| Jul 5, 2016 | 115 | JOINT APPENDIX, VOLS. 1- 3 FILED for Millennium Pharmaceuticals, Inc. [113]. Number of Pages: 1,704. Service: 07/05/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/12/2016. [349042] [CAB] [Entered: 07/07/2016 11:42 AM] (1704) |
| Jun 24, 2016 | 112 | 6 paper copies of the Reply Brief [111] received from Appellant Millennium Pharmaceuticals, Inc. [346433] [KW] [Entered: 06/24/2016 03:39 PM] (0) |
| Jun 22, 2016 | 110 | TENDERED from Appellant Millennium Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 06/22/2016 by email. [345768] [William Lee] [Entered: 06/22/2016 01:09 PM] (42) |
| Jun 22, 2016 | 111 | REPLY BRIEF FILED for Appellant Millennium Pharmaceuticals, Inc. [110]. Number of Pages: 32. Service: 06/22/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/28/2016. Appendix is due 07/05/2016. [346084] [CAB] [Entered: 06/23/2016 02:20 PM] (42) |
| May 13, 2016 | 108 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [106] filed by Appellant Millennium Pharmaceuticals, Inc. Reply brief is due 06/22/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [334888] [CAB] [Entered: 05/13/2016 11:54 AM] (0) |
| May 12, 2016 | 106 | MOTION of Appellant Millennium Pharmaceuticals, Inc. to extend the time to 06/22/2016 at 11:59 pm to file the reply brief. Response/Opposition is due 05/26/2016 [Consent: unopposed]. Service: 05/12/2016 by email. [334641] [William Lee] [Entered: 05/12/2016 03:00 PM] (9) |
| May 12, 2016 | 109 | 6 paper copies of the Response Brief [105] received from Appellees Apotex Corp., Apotex Inc., and Teva Pharmaceuticals USA, Inc. [335206] [MJL] [Entered: 05/16/2016 10:40 AM] (0) |
| May 11, 2016 | 107 | 6 paper copies of the Opening Response Brief [104] received from Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC. [334844] [MJL] [Entered: 05/13/2016 10:32 AM] (0) |
| May 6, 2016 | 102 | TENDERED from Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG and Wockhardt USA LLC. Title: RESPONSE BRIEF. Service: 05/06/2016 by email. [333051] [Gary Hood] [Entered: 05/06/2016 04:36 PM] (92) |
| May 6, 2016 | 103 | TENDERED from Appellees Apotex Corp., Apotex Inc. and Teva Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 05/06/2016 by email. [333055] [William Rakoczy] [Entered: 05/06/2016 04:40 PM] (34) |
| May 6, 2016 | 104 | BRIEF FILED for Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Wockhardt Bio AG, and Wockhardt USA LLC [102]. Number of Pages: 65. Service: 05/06/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/16/2016. [333262] [MJL] [Entered: 05/09/2016 12:00 PM] (92) |
| May 6, 2016 | 105 | BRIEF FILED for Appellees Apotex Corp., Apotex Inc. and Teva Pharmaceuticals USA, Inc. [103]. Number of Pages: 19. Service: 05/06/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/16/2016. Appellant Millennium Pharmaceuticals, Inc.'s reply brief is due 05/23/2016. [333287] [MJL] [Entered: 05/09/2016 12:53 PM] (34) |
| May 5, 2016 | 101 | Entry of appearance for Luke T. Shannon as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 05/05/2016 by email. [332631] [Luke Shannon] [Entered: 05/05/2016 05:16 PM] (2) |
| Apr 22, 2016 | 99 | Note to file: The following cases are associated:15-2066 Lead with 16-1762 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [328869] [15-2066, 16-1762] [CAB] [Entered: 04/22/2016 12:49 PM] (0) |
| Apr 22, 2016 | 100 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [328884] [CAB] [Entered: 04/22/2016 01:13 PM] (0) |
| Apr 21, 2016 | 98 | ORDER filed. The motion to consolidate [95] [327293-2] is granted. The revised official caption is reflected in the order. Appellees' response briefs are due no later than May 6, 2016. The motion for an extension of time in 2016-1762 [328368-2] is denied as moot. Service: 04/21/2016 by clerk. [328583] [15-2066, 16-1762] [LMS] [Entered: 04/21/2016 03:40 PM] (2) |
| Apr 20, 2016 | 96 | Entry of appearance for Stuart D. Sender as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/20/2016 by email. [328198] [Stuart Sender] [Entered: 04/20/2016 03:55 PM] (2) |
| Apr 20, 2016 | 97 | Amended Certificate of Interest for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 04/20/2016 by email. [328201] [Stuart Sender] [Entered: 04/20/2016 03:58 PM] (2) |
| Apr 18, 2016 | 95 | MOTION of Wockhardt Bio AG and Wockhardt USA LLC Appellant Millennium Pharmaceuticals, Inc. to consolidate appeals (2015-2066 and 2016-1762). Response/Opposition is due 05/02/2016 [Consent: unopposed]. Service: 04/18/2016 by email. [327295] [William Lee] [Entered: 04/18/2016 04:56 PM] (16) |
| Mar 28, 2016 | 93 | ORDER designating 16-1762 as a companion case to the set of cases in 15-2066 et al. 16-1762 shall be assigned to the same merits panel as the other appeals. Appellant's opening brief in 2016-1762 is due no later than April 28, 2016. Service as of this date by Clerk of Court. [322037] [16-1762, 15-2066] [JCA] [Entered: 03/28/2016 11:35 AM] (2) |
| Mar 28, 2016 | 94 | Note to file: 16-1762 (COMPANION started 03/28/2016) with 15-2066. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [322038] [JCA] [Entered: 03/28/2016 11:36 AM] (0) |
| Mar 1, 2016 | 92 | ORDER filed. The motion [91] is granted. The appellees' response briefs are due May 6, 2016. Service: 03/01/2016 by clerk. [315079] [LMS] [Entered: 03/01/2016 03:52 PM] (2) |
| Feb 25, 2016 | 91 | MOTION of Appellee Actavis LLC to extend the time to 05/06/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 03/10/2016 [Consent: unopposed]. Service: 02/25/2016 by email. [314060] [Gary Hood] [Entered: 02/25/2016 05:58 PM] (8) |
| Feb 17, 2016 | 89 | Entry of appearance for Paul M. Zagar as of counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 02/17/2016 by email. [311663] [David Dorey] [Entered: 02/17/2016 10:57 AM] (2) |
| Feb 17, 2016 | 90 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [89], ERROR: The contact information provided in your entry of appearance does not match our database.. CORRECTION: Please update your contact and firm information via the PACER service center.. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [311725] [JB] [Entered: 02/17/2016 12:47 PM] (0) |
| Jan 28, 2016 | 88 | 6 paper copies of the Opening Brief [87] received from Appellant Millennium Pharmaceuticals, Inc.. [307303] [MJL] [Entered: 02/01/2016 10:22 AM] (0) |
| Jan 22, 2016 | 86 | TENDERED from Appellant Millennium Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 01/22/2016 by email. [305571] [William Lee] [Entered: 01/22/2016 06:29 PM] (124) |
| Jan 22, 2016 | 87 | BRIEF FILED for Appellant Millennium Pharmaceuticals, Inc. [86]. Number of Pages: 64. Service: 01/22/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/01/2016. Appellees Accord Healthcare Inc., Actavis LLC, Agila Specialties Inc., Apotex Corp., Apotex Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hospira, Inc., Mylan Laboratories Limited, Sandoz Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc. brief is due 03/07/2016. [306081] [JB] [Entered: 01/27/2016 01:55 PM] (124) |
| Jan 19, 2016 | 85 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Hospira, Inc.. Service: 01/19/2016 by email. [304345] [Michael Johnson] [Entered: 01/19/2016 05:35 PM] (3) |
| Dec 18, 2015 | 81 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellee Hospira, Inc.. Service: 12/18/2015 by email. [297705] [Thomas Meloro] [Entered: 12/18/2015 05:54 PM] (2) |
| Dec 18, 2015 | 82 | Entry of appearance for Michael W. Johnson as of counsel for Appellee Hospira, Inc.. Service: 12/18/2015 by email. [297706] [Michael Johnson] [Entered: 12/18/2015 05:57 PM] (2) |
| Dec 18, 2015 | 83 | Certificate of Interest for the Appellee Hospira, Inc.. Service: 12/18/2015 by email. [297707] [Thomas Meloro] [Entered: 12/18/2015 06:00 PM] (2) |
| Dec 18, 2015 | 84 | Docketing Statement for the Appellee Hospira, Inc.. Service: 12/18/2015 by email. [297708] [Thomas Meloro] [Entered: 12/18/2015 06:02 PM] (4) |
| Dec 8, 2015 | 78 | ORDER consolidating appeals (15-2066, 16-1283). Service as of this date by Clerk of Court. [294530] [15-2066, 16-1283] [LN] [Entered: 12/08/2015 12:52 PM] (2) |
| Dec 8, 2015 | 79 | Official caption revised cases consolidated. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [294535] [LN] [Entered: 12/08/2015 01:00 PM] (0) |
| Dec 8, 2015 | 80 | Clerk's Note to the File: The following cases are associated: 15-2066 (Lead) with 16-1283 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY.. [294537] [LN] [Entered: 12/08/2015 01:03 PM] (0) |
| Nov 25, 2015 | 77 | ORDER granting motion to modify the official caption [69] filed by Appellee Actavis LLC. The revised official caption is reflected in the order. Service: 11/25/2015 by clerk. [291858] [LMS] [Entered: 11/25/2015 01:05 PM] (2) |
| Nov 20, 2015 | 76 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/20/2015 by email. [290416] [Mark Schuman] [Entered: 11/20/2015 12:00 PM] (3) |
| Nov 19, 2015 | 70 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited. Service: 11/19/2015 by email. [289958] [Rachel Hughey] [Entered: 11/19/2015 10:07 AM] (0) |
| Nov 19, 2015 | 71 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 11/19/2015 by email. [289979] [Louis Weinstein] [Entered: 11/19/2015 11:01 AM] (4) |
| Nov 19, 2015 | 73 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited. Service: 11/19/2015 by email. [289993] [Rachel Hughey] [Entered: 11/19/2015 11:28 AM] (4) |
| Nov 19, 2015 | 74 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 11/19/2015 by email. [290188] [Elham Steiner] [Entered: 11/19/2015 03:47 PM] (5) |
| Nov 19, 2015 | 75 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Apotex Corp. and Apotex Inc.. Service: 11/19/2015 by email. [290214] [Peter Curtin] [Entered: 11/19/2015 04:17 PM] (3) |
| Nov 18, 2015 | 72 | NOTICE OF DEFICIENCY: The compliance document Document No. [70] filed by Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited in 15-2066 cannot be accepted for filing at this time. The document is dated "November 19, 2016". You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [289981] [JCA] [Entered: 11/19/2015 11:09 AM] (0) |
| Nov 16, 2015 | 69 | MOTION of Appellee Actavis LLC to modify the official caption. Response/Opposition is due 12/03/2015 [Consent: unopposed]. Service: 11/16/2015 by email. [288934] [Gary Hood] [Entered: 11/16/2015 01:21 PM] (5) |
| Nov 10, 2015 | 68 | Entry of appearance for Thomas H. Ehrich as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 11/10/2015 by email. [287881] [Thomas Ehrich] [Entered: 11/10/2015 05:05 PM] (3) |
| Nov 9, 2015 | 64 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Accord Healthcare Inc.. Service: 11/09/2015 by email. [287457] [Paul Braier] [Entered: 11/09/2015 05:11 PM] (2) |
| Nov 9, 2015 | 65 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Actavis Inc. and Actavis LLC. Service: 11/09/2015 by email. [287468] [Gary Hood] [Entered: 11/09/2015 05:51 PM] (4) |
| Nov 9, 2015 | 66 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Millennium Pharmaceuticals, Inc.. Service: 11/09/2015 by email. [287482] [William Lee] [Entered: 11/09/2015 07:49 PM] (4) |
| Nov 9, 2015 | 67 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Sandoz Inc.. Service: 11/09/2015 by email. [287490] [Kathleen Barry] [Entered: 11/09/2015 10:26 PM] (2) |
| Nov 6, 2015 | 56 | Entry of appearance for Mark D. Schuman as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286932] [Mark Schuman] [Entered: 11/06/2015 12:19 PM] (3) |
| Nov 6, 2015 | 57 | Entry of appearance for Todd S. Werner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286933] [Todd Werner] [Entered: 11/06/2015 12:21 PM] (3) |
| Nov 6, 2015 | 58 | Entry of appearance for Samuel T. Lockner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286934] [Samuel Lockner] [Entered: 11/06/2015 12:22 PM] (3) |
| Nov 6, 2015 | 59 | Entry of appearance for Jennell C. Bilek as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286936] [Jennell Bilek] [Entered: 11/06/2015 12:24 PM] (3) |
| Nov 6, 2015 | 60 | Entry of appearance for Alexandra J. Olson as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286937] [Alexandra Olson] [Entered: 11/06/2015 12:25 PM] (3) |
| Nov 6, 2015 | 61 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286938] [Mark Schuman] [Entered: 11/06/2015 12:27 PM] (3) |
| Nov 6, 2015 | 62 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/06/2015 by email. [286939] [Mark Schuman] [Entered: 11/06/2015 12:27 PM] (5) |
| Nov 6, 2015 | 63 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Christopher K. Hu for Glenmark Generics Inc., USA, Glenmark Pharmaceuticals Ltd. and Glenmark Generics Ltd. An e-mail address associated with your CM/ECF account, (cyeddo@blankrome.com), is invalid and has been returned as undeliverable. Pursuant to ECF-2(E) of the Administrative Order Regarding Electronic Case Filing, an ECF filer must update all contact information with the Pacer Service Center. Counsel should promptly update his account information with the Pacer Service Center at www.pacer.gov. [286984] [IW] [Entered: 11/06/2015 01:40 PM] (0) |
| Nov 5, 2015 | 45 | Entry of appearance for Jay Philip Lessler as principal counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 11/05/2015 by email. [286633] [David Dorey] [Entered: 11/05/2015 03:20 PM] (2) |
| Nov 5, 2015 | 46 | Entry of appearance for Christopher K. Hu as of counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 11/05/2015 by email. [286634] [David Dorey] [Entered: 11/05/2015 03:22 PM] (2) |
| Nov 5, 2015 | 47 | Entry of appearance for David A. Dorey as of counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 11/05/2015 by email. [286635] [David Dorey] [Entered: 11/05/2015 03:23 PM] (2) |
| Nov 5, 2015 | 48 | Certificate of Interest for the Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 11/05/2015 by email. [286636] [David Dorey] [Entered: 11/05/2015 03:25 PM] (2) |
| Nov 5, 2015 | 49 | Docketing Statement for the Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 11/05/2015 by email. [286637] [David Dorey] [Entered: 11/05/2015 03:25 PM] (4) |
| Nov 5, 2015 | 50 | Entry of appearance for Mark D. Schuman as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/04/2015 by email. [286706] [Mark Schuman] [Entered: 11/05/2015 04:48 PM] (1) |
| Nov 5, 2015 | 51 | Entry of appearance for Todd S. Werner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286708] [Todd Werner] [Entered: 11/05/2015 04:50 PM] (1) |
| Nov 5, 2015 | 52 | Entry of appearance for Samuel T. Lockner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286712] [Samuel Lockner] [Entered: 11/05/2015 04:55 PM] (1) |
| Nov 5, 2015 | 53 | Entry of appearance for Jennell C. Bilek as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286714] [Jennell Bilek] [Entered: 11/05/2015 04:57 PM] (1) |
| Nov 5, 2015 | 54 | Entry of appearance for Alexandra J. Olson as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286718] [Alexandra Olson] [Entered: 11/05/2015 04:59 PM] (1) |
| Nov 5, 2015 | 55 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286721] [Mark Schuman] [Entered: 11/05/2015 05:02 PM] (1) |
| Nov 3, 2015 | 44 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [41], ERROR: Counsel Peter J. Curtin has not registered for CM/ECF. Pursuant to ECF-2(A) of the Administrative Order regarding electronic filing, counsel who appear before this court must register for the court's CM/ECF system. CORRECTION: Counsel should promptly register for CM/ECF at www.PACER.gov. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [285542]--[Edited 11/04/2015 by clerk to correct docket text] [NL] [Entered: 11/03/2015 09:24 AM] (0) |
| Nov 2, 2015 | 39 | CORRECTED ORDER: correcting clerk order to consolidate appeals [36], clerk order [36]; reason(s): to correct appellant's opening brief deadline. Service as of this date by Clerk of Court. [285098] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 11/02/2015 09:52 AM] (2) |
| Nov 2, 2015 | 40 | Entry of appearance for William A. Rakoczy as principal counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 11/02/2015 by US mail, email. [285445] [William Rakoczy] [Entered: 11/02/2015 06:38 PM] (3) |
| Nov 2, 2015 | 41 | Entry of appearance for Peter J. Curtin as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 11/02/2015 by US mail, email. [285447] [William Rakoczy] [Entered: 11/02/2015 06:41 PM] (3) |
| Nov 2, 2015 | 42 | Docketing Statement for the Appellees Apotex Corp. and Apotex Inc.. Service: 11/02/2015 by US mail, email. [285448] [William Rakoczy] [Entered: 11/02/2015 06:43 PM] (5) |
| Nov 2, 2015 | 43 | Certificate of Interest for the Appellees Apotex Corp. and Apotex Inc.. Service: 11/02/2015 by US mail, email. [285449] [William Rakoczy] [Entered: 11/02/2015 06:45 PM] (3) |
| Oct 30, 2015 | 36 | ORDER consolidating appeals (15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110). Service as of this date by Clerk of Court. [284905] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 02:55 PM] (0) |
| Oct 30, 2015 | 37 | Official caption revised cases consolidated. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [284929] [CAB] [Entered: 10/30/2015 03:28 PM] (0) |
| Oct 30, 2015 | 38 | Note to file: The following cases are associated:15-2066 (Lead) with 16-1008, -1009, -1010, -1109, and -1110 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [284931] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 03:33 PM] (0) |
| Oct 29, 2015 | 34 | MOTION of Appellant Millennium Pharmaceuticals, Inc. to extend the time to 01/22/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 11/12/2015 [Consent: unopposed]. Service: 10/29/2015 by email. [284328] [William Lee] [Entered: 10/29/2015 10:13 AM] (8) |
| Oct 29, 2015 | 35 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [34] filed by Appellant Millennium Pharmaceuticals, Inc. Brief due 01/22/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [284439] [CAB] [Entered: 10/29/2015 01:06 PM] (0) |
| Oct 22, 2015 | 33 | Entry of appearance for Emily R. Whelan as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/22/2015 by email. [282719] [Emily Whelan] [Entered: 10/22/2015 11:59 AM] (2) |
| Oct 20, 2015 | 32 | Entry of appearance for Khurram Naik as of counsel for Appellees Actavis Inc. and Actavis LLC. Service: 10/20/2015 by email. [282037] [Khurram Naik] [Entered: 10/20/2015 03:54 PM] (2) |
| Oct 16, 2015 | 30 | Corrected Docketing Statement for the Appellant Millennium Pharmaceuticals, Inc.. Service: 10/16/2015 by email. [280882] [William Lee] [Entered: 10/16/2015 09:28 AM] (4) |
| Oct 16, 2015 | 31 | Note to file: 16-1008, 16-1009, 16-1010 (COMPANION started 10/16/2015) with 15-2066. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [281115] [15-2066, 16-1008, 16-1009, 16-1010] [CAB] [Entered: 10/16/2015 04:19 PM] (0) |
| Oct 8, 2015 | 2 | Entry of appearance for Paul A. Braier as principal counsel for Appellee Accord Healthcare Inc.. Service: 10/08/2015 by email. [278820] [Paul Braier] [Entered: 10/08/2015 01:04 PM] (2) |
| Oct 8, 2015 | 3 | Entry of appearance for P. Branko Pejic as of counsel for Appellee Accord Healthcare Inc.. Service: 10/08/2015 by email. [278823] [Paul Braier] [Entered: 10/08/2015 01:05 PM] (2) |
| Oct 8, 2015 | 4 | Certificate of Interest for the Appellee Accord Healthcare Inc.. Service: 10/08/2015 by email. [278852] [Paul Braier] [Entered: 10/08/2015 01:50 PM] (2) |
| Oct 8, 2015 | 5 | Docketing Statement for the Appellee Accord Healthcare Inc.. Service: 10/08/2015 by email. [278857] [Paul Braier] [Entered: 10/08/2015 01:53 PM] (4) |
| Oct 8, 2015 | 6 | Entry of appearance for William F. Lee as principal counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278888] [William Lee] [Entered: 10/08/2015 02:42 PM] (2) |
| Oct 8, 2015 | 7 | Entry of appearance for Lisa J. Pirozzolo as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278889] [Lisa Pirozzolo] [Entered: 10/08/2015 02:44 PM] (2) |
| Oct 8, 2015 | 8 | Entry of appearance for Robert M. Galvin as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278892] [Lisa Pirozzolo] [Entered: 10/08/2015 02:46 PM] (2) |
| Oct 8, 2015 | 9 | Entry of appearance for Mark C. Fleming as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278893] [Mark Fleming] [Entered: 10/08/2015 02:48 PM] (2) |
| Oct 8, 2015 | 10 | Entry of appearance for Jason H. Liss as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278895] [Jason Liss] [Entered: 10/08/2015 02:50 PM] (2) |
| Oct 8, 2015 | 11 | Entry of appearance for Anna E. Lumelsky as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278899] [Anna Lumelsky] [Entered: 10/08/2015 02:51 PM] (2) |
| Oct 8, 2015 | 12 | Entry of appearance for Tasha J. Bahal as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278903] [Tasha Bahal] [Entered: 10/08/2015 02:53 PM] (2) |
| Oct 8, 2015 | 13 | Certificate of Interest for the Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278907] [William Lee] [Entered: 10/08/2015 02:55 PM] (2) |
| Oct 8, 2015 | 14 | Docketing Statement for the Appellant Millennium Pharmaceuticals, Inc.. Service: 10/08/2015 by email. [278909] [William Lee] [Entered: 10/08/2015 02:56 PM] (4) |
| Oct 8, 2015 | 15 | Entry of appearance for George C. Lombardi as principal counsel for Appellee Sandoz Inc.. Service: 10/08/2015 by email. [278954] [George Lombardi] [Entered: 10/08/2015 03:37 PM] (2) |
| Oct 8, 2015 | 16 | Entry of appearance for Maureen L. Rurka as of counsel for Appellee Sandoz Inc.. Service: 10/08/2015 by email. [278963] [Maureen Rurka] [Entered: 10/08/2015 03:47 PM] (2) |
| Oct 8, 2015 | 17 | Entry of appearance for Gary E. Hood as principal counsel for Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [278990] [Gary Hood] [Entered: 10/08/2015 04:05 PM] (2) |
| Oct 8, 2015 | 18 | Certificate of Interest for the Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [278993] [Gary Hood] [Entered: 10/08/2015 04:09 PM] (3) |
| Oct 8, 2015 | 19 | Docketing Statement for the Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [278996] [Gary Hood] [Entered: 10/08/2015 04:11 PM] (3) |
| Oct 8, 2015 | 20 | Entry of appearance for Kathleen B. Barry as of counsel for Appellee Sandoz Inc.. Service: 10/08/2015 by email. [278997] [Kathleen Barry] [Entered: 10/08/2015 04:11 PM] (2) |
| Oct 8, 2015 | 21 | Certificate of Interest for the Appellee Sandoz Inc.. Service: 10/08/2015 by email. [279005] [Kathleen Barry] [Entered: 10/08/2015 04:14 PM] (2) |
| Oct 8, 2015 | 22 | NOTICE OF DEFICIENCY: The parties listed on the attorney entry of appearance Document No. [17] filed by Appellees Actavis LLC and Actavis Inc. in 15-2066 does not match the docket text (A motion to revise the caption may be required). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [279010] [JAB] [Entered: 10/08/2015 04:19 PM] (0) |
| Oct 8, 2015 | 23 | Docketing Statement for the Appellee Sandoz Inc.. Service: 10/08/2015 by email. [279011] [Kathleen Barry] [Entered: 10/08/2015 04:20 PM] (4) |
| Oct 8, 2015 | 24 | Corrected Docketing Statement for the Appellee Accord Healthcare Inc.. Service: 10/08/2015 by email. [279019] [Paul Braier] [Entered: 10/08/2015 04:35 PM] (4) |
| Oct 8, 2015 | 25 | Corrected Entry of appearance for Gary E. Hood as principal counsel for Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [279028] [Gary Hood] [Entered: 10/08/2015 04:49 PM] (2) |
| Oct 8, 2015 | 26 | Entry of appearance for Mark T. Deming as of counsel for Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [279036] [Mark Deming] [Entered: 10/08/2015 04:56 PM] (2) |
| Oct 8, 2015 | 27 | Corrected Certificate of Interest for the Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [279038] [Gary Hood] [Entered: 10/08/2015 05:03 PM] (3) |
| Oct 8, 2015 | 28 | Docketing Statement for the Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [279039] [Gary Hood] [Entered: 10/08/2015 05:05 PM] (4) |
| Oct 8, 2015 | 29 | Entry of appearance for Robyn H. Ast-Gmoser as of counsel for Appellees Actavis Inc. and Actavis LLC. Service: 10/08/2015 by email. [279041] [Robyn Ast-Gmoser] [Entered: 10/08/2015 05:12 PM] (2) |
| Sep 24, 2015 | 1 | Appeal docketed. Received: 09/22/2015. [274905]Entry of Appearance due 10/08/2015. Certificate of Interest is due on 10/08/2015. Docketing Statement due 10/08/2015. Appellant/Petitioner's brief is due 11/23/2015. [SJ] [Entered: 09/24/2015 03:04 PM] (22) |
